APA (7th ed.) Citation

Täger, T., Frankenstein, L., Atar, D., Agewall, S., Frey, N., Grundtvig, M., . . . Fröhlich, H. (2022). Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: A systematic review and head-to-head comparative efficacy network meta-analysis. Clinical research in cardiology, 111(4), . https://doi.org/10.1007/s00392-021-01913-z

Chicago Style (17th ed.) Citation

Täger, Tobias, Lutz Frankenstein, Dan Atar, Stefan Agewall, Norbert Frey, Morten Grundtvig, Andrew L. Clark, John G. F. Cleland, and Hanna Fröhlich. "Influence of Receptor Selectivity on Benefits from SGLT2 Inhibitors in Patients with Heart Failure: A Systematic Review and Head-to-head Comparative Efficacy Network Meta-analysis." Clinical Research in Cardiology 111, no. 4 (2022). https://doi.org/10.1007/s00392-021-01913-z.

MLA (9th ed.) Citation

Täger, Tobias, et al. "Influence of Receptor Selectivity on Benefits from SGLT2 Inhibitors in Patients with Heart Failure: A Systematic Review and Head-to-head Comparative Efficacy Network Meta-analysis." Clinical Research in Cardiology, vol. 111, no. 4, 2022, https://doi.org/10.1007/s00392-021-01913-z.